quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:40:21·1584d
NEWSRelease
Evofem Biosciences Inc. logo
Immix Biopharma Inc. logo
Osmotica Pharmaceuticals plc logo
+1

4 Penny Stocks Insiders Are Buying

EVFM· Evofem Biosciences Inc.IMMX· Immix Biopharma Inc.OSMT· Osmotica Pharmaceuticals plcSTRM· Streamline Health Solutions Inc.
Health CareTechnology
Original source

Companies

  • EVFM
    Evofem Biosciences Inc.
    Health Care
  • IMMX
    Immix Biopharma Inc.
    Health Care
  • OSMT
    Osmotica Pharmaceuticals plc
    Health Care
  • STRM
    Streamline Health Solutions Inc.
    Technology

Recent analyst ratings

  • Mar 25IMMXUpdateMorgan Stanley$20.00
  • Mar 9IMMXUpdateCitizens$23.00
  • Feb 9IMMXUpdateMizuho$14.00
  • Nov 21STRMUpdateLake Street$3.00
  • Mar 4EVFMUpdateMorgan Stanley$0.53
  • Dec 23OSMTUpdateHC Wainwright & Co.$5.00

Related

  • SEC7d
    Evofem Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
  • PR14d
    Immix Biopharma to Participate in the Jefferies Global Healthcare Conference
  • SEC17d
    SEC Form DEFA14A filed by Immix Biopharma Inc.
  • SEC17d
    SEC Form DEF 14A filed by Immix Biopharma Inc.
  • SEC24d
    Immix Biopharma Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • SEC27d
    Amendment: SEC Form 10-K/A filed by Immix Biopharma Inc.
  • SEC29d
    SEC Form S-8 filed by Immix Biopharma Inc.
  • SEC29d
    Immix Biopharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022